Follicular dendritic cell sarcoma and its response to immune checkpoint inhibitors nivolumab and ipilimumab
- 1 April 2020
- journal article
- research article
- Published by BMJ in BMJ Case Reports
- Vol. 13 (4), e234363
- https://doi.org/10.1136/bcr-2020-234363
Abstract
Follicular dendritic cell sarcoma (FDCS) is a rare and unusual cancer that arises from sustentacular cells of the lymph node that present antigen to B cells, rather than lymphocytes themselves. While surgery for primary disease is still paramount in primary management, for unresectable, recurrent and metastatic tumours, FDCS is frequently treated with anthracycline-based lymphoma chemotherapy regimens. In recent years, it is clear that Programmed Cell Death 1 (PD1)-directed immune checkpoint inhibitors (ICIs) are active in Hodgkin lymphoma, but significantly less active in non-Hodgkin's lymphoma. These data raised the question of whether FDCS respond to ICI therapy. We present two patients with FDCS who were treated with nivolumab and ipilimumab with evidence of tumour response. These cases also highlight the difficulty in arriving at a proper diagnosis, emphasising the need for expert review of pathology to optimise treatment for these and other patients with sarcoma.Keywords
This publication has 24 references indexed in Scilit:
- Expression of Programmed Cell Death 1 Ligands (PD-L1 and PD-L2) in Histiocytic and Dendritic Cell DisordersThe American Journal of Surgical Pathology, 2016
- Vemurafenib in Multiple Nonmelanoma Cancers with BRAF V600 MutationsNew England Journal of Medicine, 2015
- Impact of surgery, radiation and systemic therapy on the outcomes of patients with dendritic cell and histiocytic sarcomasEuropean Journal of Cancer, 2015
- Reproducible and Sustained Efficacy of Targeted Therapy With Vemurafenib in Patients With BRAFV600E-Mutated Erdheim-Chester DiseaseJournal of Clinical Oncology, 2015
- Fate mapping reveals origin and dynamics of lymph node follicular dendritic cellsThe Journal of Experimental Medicine, 2014
- Inflammatory Pseudotumor-like Follicular Dendritic Cell Tumor of Liver and SpleenThe American Journal of Surgical Pathology, 2014
- Interdigitating and Follicular Dendritic Cell SarcomasAmerican Journal of Clinical Oncology, 2013
- We Should Desist Using RECIST, at Least in GISTJournal of Clinical Oncology, 2007
- Correlation of Computed Tomography and Positron Emission Tomography in Patients With Metastatic Gastrointestinal Stromal Tumor Treated at a Single Institution With Imatinib Mesylate: Proposal of New Computed Tomography Response CriteriaJournal of Clinical Oncology, 2007
- Follicular Dendritic Cell TumorThe American Journal of Surgical Pathology, 1996